India currently contributes three-to-five per cent share of the global biotechnology sector Read more
Windlas Biotech, Mateon Therapeutics partner to launch combined lung therapy and AI telemedicine solution Read more
We might need to redefine our approach to drug discovery and approval to be prepared for the future Read more